Novartis pushes forward with Covid drug after positive trial: Bloomberg ruchika12 Jan 2022 8:41 AM GMTNovartis's medicine is given via an intravenous infusion, making a doctor's visit necessary.
Novartis gets CDSCO panel nod to study Alpelisib for early (prophylactic) and sustained improvement of hyperglycemia Medical Dialogues Team9 Jan 2022 3:15 PM GMTNew Delhi: Pharmaceutical major Novartis has got a conditional nod from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Novartis gets CDSCO panel nod to study Ligelizumab in treatment of chronic inducible urticaria Medical Dialogues Team7 Jan 2022 8:51 AM GMTNew Delhi: Pharma major Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Novartis wins appeal over MS drug Gilenya patent: Bloomberg Medical Dialogues Bureau5 Jan 2022 4:30 AM GMTThe issue on appeal was whether the patent clearly explained the dosage regimen for fingolimod, the active ingredient in Gilenya, without the need for ...
Novartis Cosentyx gets USFDA approval ruchika26 Dec 2021 4:15 AM GMTBasel: Novartis has announced the US Food and Drug Administration (USFDA) has approved Cosentyx (secukinumab) for the treatment of active enthesit...
Ligelizumab fails to show superiority to omalizumab in chronic spontaneous urticaria: Clinical trials Hina Zahid25 Dec 2021 3:30 AM GMTLigelizumab, an investigational treatment for chronic spontaneous urticaria (CSU), failed to show superiority to omalizumab in two identical phase 3...
Delhi HC restrains Natco from infringing Novartis API containing Eltrombopag Olamine Medical Dialogues Team22 Dec 2021 12:56 PM GMTNew Delhi: In a major relief to Novartis, the Delhi High Court has restrained Natco Pharma from using, manufacturing , importing, selling, offering for...
Working on pan-coronavirus oral treatment: Novartis CEO ruchika7 Dec 2021 9:16 AM GMTNew Delhi: Novartis hopes to still play a role in the development of COVID-19 treatments with research ongoing for a pill that could work broadly again...
Pfizer vaccine executive Phil Dormitzer to join GSK as Global Head of Vaccines RnD ruchika1 Dec 2021 6:30 AM GMTUnited Kingdom: Drug maker, GSK, has recently announced that Phil Dormitzer M.D., Ph.D., will join the company as Global Head of Vaccines R&D on 3 ...
Health Bulletin 26/November/2021 Roshni Dhar26 Nov 2021 12:12 PM GMTHere are Top Health stories of the dayHospitals Demand Revision of CGHS rates, Minister promises early actionDoctors and Hospitals working under Centra...
Health Bulletin 25/November/2021 Roshni Dhar25 Nov 2021 12:45 PM GMTHere are Top Health stories of the dayDoctors Shortage In Govt Run Hospitals: Delhi High Court Issues Notice On Plea For Filling Vacancies as soon as ...
Sun Pharma to face antitrust trial over Diovan, Nexium, Valcyte Hina Zahid25 Nov 2021 11:04 AM GMTNew Delhi: Sun Pharmaceutical Industries Ltd has lost a bid to avoid facing a trial over allegations that an Indian drug maker it acquired engaged in a...
